$19.85
1.54% day before yesterday
Nasdaq, Dec 27, 10:00 pm CET
ISIN
US74276R1023
Symbol
PRVA

Privia Health Group Stock price

$19.85
-1.81 8.36% 1M
+2.73 15.95% 6M
-3.18 13.81% YTD
-4.37 18.04% 1Y
-6.44 24.50% 3Y
-14.90 42.88% 5Y
-14.90 42.88% 10Y
Nasdaq, Closing price Fri, Dec 27 2024
-0.31 1.54%
ISIN
US74276R1023
Symbol
PRVA
Industry

Key metrics

Market capitalization $2.38b
Enterprise Value $2.01b
P/E (TTM) P/E ratio 193.85
EV/FCF (TTM) EV/FCF 21.52
EV/Sales (TTM) EV/Sales 1.17
P/S ratio (TTM) P/S ratio 1.39
P/B ratio (TTM) P/B ratio 3.87
Revenue growth (TTM) Revenue growth 8.54%
Revenue (TTM) Revenue $1.72b
EBIT (operating result TTM) EBIT $13.15m
Free Cash Flow (TTM) Free Cash Flow $93.56m
Cash position $422.00m
EPS (TTM) EPS $0.10
P/E forward 151.11
P/S forward 1.40
EV/Sales forward 1.19
Short interest 7.59%
Show more

Is Privia Health Group a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Privia Health Group Stock Analysis

Unlock Scores for Free

Analyst Opinions

23 Analysts have issued a Privia Health Group forecast:

21x Buy
91%
2x Hold
9%

Analyst Opinions

23 Analysts have issued a Privia Health Group forecast:

Buy
91%
Hold
9%

Financial data from Privia Health Group

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
1,716 1,716
9% 9%
100%
- Direct Costs 1,556 1,556
9% 9%
91%
161 161
5% 5%
9%
- Selling and Administrative Expenses 140 140
11% 11%
8%
- Research and Development Expense - -
-
-
20 20
26% 26%
1%
- Depreciation and Amortization 7.21 7.21
22% 22%
0%
EBIT (Operating Income) EBIT 13 13
39% 39%
1%
Net Profit 13 13
66% 66%
1%

In millions USD.

Don't miss a Thing! We will send you all news about Privia Health Group directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Privia Health Group Stock News

Neutral
Seeking Alpha
about 2 months ago
Privia Health Group, Inc. (NASDAQ:PRVA ) Q3 2024 Earnings Conference Call November 7, 2024 8:00 AM ET Company Participants Robert Borchert - Senior Vice President- Investor & Corporate Communications Parth Mehrotra - Chief Executive Officer David Mountcastle - Chief Financial Officer Conference Call Participants A.J. Rice - UBS Andrew Mok - Barclays Richard Close - Canaccord Genuity Jailendra S...
Neutral
GlobeNewsWire
about 2 months ago
ARLINGTON, Va., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial results for the third quarter and nine months ended September 30, 2024.
Neutral
GlobeNewsWire
2 months ago
Privia Health Reports 2023 Performance Results in the Medicare Shared Savings Program; $176.6M in Shared Savings Delivered Across 10 Participating ACOs
More Privia Health Group News

Company Profile

Privia Health Group, Inc. engages in healthcare services. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experience, and reward doctors for delivering care both in-person and, via its Privia Platform, virtual care settings. The company was founded by Jeffrey Butler on November 7, 2007 and is headquartered in Arlington, VA.

Head office United States
CEO Parth Mehrotra
Employees 1,102
Founded 2007
Website www.priviahealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today